| GlaxoSmithKline AG - Daraprim, Tabletten |
| 20964 | | 01 | | Daraprim | | Tabletten | | P01BD01 | | Pyrimethamine | | 22.02.1955 | | |
|
| Composition |
| pyrimethaminum 25 mg, lactosum monohydricum 90 mg, maydis amylum, amylum hydrolysatum, magnesii stearas, natrii docusas, pro compresso corresp. natrium 0.0006 mg. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Pyrimethamine | 25 mg |
| | BAG: Active Agent | Dose |
|---|
| Pyrimethamine | 25 mg |
| | | | Inactive agents | Dose |
|---|
| Amylum Hydrolysatum | | | Lactose Monohydrate | 90 mg | | Magnesii Stearas | | | Maydis Amylum | | | Natrii Docusas | | | Pro Compresso | |
| |
|
| Teilbarkeit |
| | Ja | | | | Ja | | | | Ja | | | | -- | | | | | | | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 13.48 | 31.10 | B | SL | No |
|
